Back Home Advertising Visit WashingtonTimes.com
 

Home...Europe...Denmark...
DENMARK2002

Medicon Valley Academy leads biotech

The Øresund bridge connects Denmark with Sweden.
Courtesy Wonderful Copenhagen

Medicon Valley Academy (MVA) is a binational network organization working on both the Danish and Swedish sides of the Øresund, the body of water that separates the two countries. MVA comprises all of the hospitals and universities in the region and 250 pharmaceutical companies are members.

The Øresund region is a geographical way of describing eastern Denmark and southern Sweden. It has three million inhabitants, 11 universities, 29 hospitals and 350 biotech and pharmaceutical companies. It is the third-largest medical hub in Europe.

Bent Christensen, the director of MVA, says “I present to the board a vision for the future whenever it needs to be revised,” he says, “presenting the region internationally to the world. We always have Swedish and Danish representatives in the board meetings.”

The idea for the network came in the early ‘80s, initiated by the universities, and has grown steadily since then. “We were very much inspired by Silicon Valley in the early '90s," Christensen says, "when they started discussing possibilities of binational networks in Life Sciences. What really made the breakthrough were the EU framework programs. We are about to commence the sixth framework programs, which will program support and funding of research and development all over Europe."

MVA was turned into a member organization in 1999. “It is quite a unique network between hospital, industry and universities, unlike any in the world as far as I know,” Christensen says.

Did the existence of Medicon Valley influence the decision to build and finance the Øresund Bridge? “No, but the bridge made the opportunities obvious and viable.”

The Danish government has signed the Barcelona Agreement on research and development funding, and Denmark should be equal with other EU countries by 2010. How are world-class scientists treated here?

“We still have this Jante lov, don’t think you are better than me," Christensen says. "Yet, if they understand to behave like normal people we will respect their achievements. You should not put yourself on a pedestal. If you don’t understand this, you will never be accepted.

“The EU has been a big influence, because we don’t see ourselves as an isolated island in EU biotech. If we are going to be competitive with the U.S., then all the clusters in Europe have to cooperate.”

For more information please visit: www.mva.org



SPONSORS

Systematic Software Engineering
Terma
Lundbeck
Marriott Hotel Copenhagen
Radisson SAS Royal Hotel
SAS
Danfoss
A.P. Moller (Maersk)
Ferring Pharmaceuticals
CMC Biopharmaceuticals
TEAM
Project Director
Maxwell Orme Johnson
Writen By
Kevin Lambert
(unless otherwise noted)
Special Thanks To:

The Royal Danish Embassy in Washington, D.C.

Stephen Brugger
AmCham, Copenhagen

Suzanne Kurstein
DABF

 

© InternationalReports.net / The Washington Times 1994-2006

 
The Washington Times